Illinois 2025-2026 Regular Session

Illinois House Bill HB1143

Introduced
1/9/25  
Refer
1/9/25  
Refer
3/12/26  

Caption

ILLINOIS CURE ACT

Impact

The legislation is expected to significantly alter state laws regarding the treatment of psilocybin as a controlled substance, aiming to integrate psilocybin therapies into public health initiatives. Key provisions include the establishment of service centers where trained facilitators can administer psilocybin to clients in a controlled environment. This move positions Illinois among a growing number of states that are exploring alternative medicinal uses for psychedelics, potentially influencing public health policies and practices statewide. The bill also ensures that psilocybin products are regulated, promoting safety and accountability in their use.

Summary

House Bill 1143 proposes a comprehensive regulatory framework for the use and provision of psilocybin services in Illinois. The bill aims to establish psilocybin as a regulated substance intended for therapeutic purposes, specifically targeting the treatment of mental health disorders. It permits adults aged 21 and over to possess psilocybin for personal use while also eliminating criminal penalties related to its possession. The bill emphasizes a compassionate and harm reduction approach, recognizing psilocybin's potential effectiveness in treating conditions such as depression, anxiety, and PTSD.

Contention

Notably, SB1143 has sparked discussions regarding local government authority over drug regulation and the implications for schools and neighborhoods. Local governments are precluded from imposing taxes or regulations on psilocybin services, which some view as an overreach of state power at the expense of local control. Additionally, there are concerns regarding the age verification processes and the training of facilitators, as the bill places significant responsibility on the Department of Financial and Professional Regulation to ensure compliance with safety and health standards. The responses to these aspects of the bill reflect a broader debate about balancing access to mental health treatments and ensuring community safety.

Companion Bills

No companion bills found.

Previously Filed As

IL HB1217

REPEAL ILLINOIS TRUST ACT

IL HB1029

REPEAL ILLINOIS TRUST ACT

IL HB1317

REPEAL ILLINOIS TRUST ACT

IL HB1345

REPEAL ILLINOIS TRUST ACT

IL SB1316

REPEAL ILLINOIS TRUST ACT

IL HB1147

BUILD ILLINOIS HOMES ACT

IL SB0062

BUILD ILLINOIS HOMES ACT

IL SB2115

HOUSE ILLINOIS FAMILIES ACT

IL HB2829

LIQUOR-ILLINOIS WINE PROMOTION

IL HB3349

POWERING UP ILLINOIS ACT

Similar Bills

NH HB1796

Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

IA HF978

A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)

IA HF620

A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.)

IA HF2085

A bill for an act relating to the production and administration of psilocybin and providing penalties.

NJ S3148

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

NH HB1809

Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

NM SB219

Medical Psilocybin Act

MA H4050

To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof